Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis Renews Microarray Service Contract with Duke

NEW YORK, June 3 (GenomeWeb News) - Expression Analysis has renewed and extended a 2001 Affymetrix microarray service agreement with Duke University Medical Center, the company said yesterday.


Expression Analysis, based in Durham, NC, will continue to provide microarray analysis services to Duke for at least three and up to five years, using the Affymetrix platform.


The company said it will soon expand its services to include RNA isolation from paraffin-embedded tissue and genotyping.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.